FDA Drug Recalls

Recalls / Class II

Class IID-0866-2020

Product

Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD

Affected lot / code info
K800475 exp. date May 2020 K800477 exp. date June 2020

Why it was recalled

Failed Impurities/Degradation Specification; high out of specification results observed

Recalling firm

Firm
Lupin Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
Harborplace Tower, 111 S Calvert St Fl 21st, Baltimore, Maryland 21202-6174

Distribution

Quantity
876 bottles
Distribution pattern
Product was distributed throughout the United States.

Timeline

Recall initiated
2020-02-19
FDA classified
2020-03-03
Posted by FDA
2020-03-11
Terminated
2021-06-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0866-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.